Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.45 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.37 |
| ▸ | KDM4A | O75164 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.37 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.36 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18827228 | 0.97 | SMN1; SMN2 (0.42) | SMN1; SMN2HPGDHTTSLC6A5PAOX | |
| SCHEMBL27249964 | 0.96 | SMN1; SMN2 (0.46) | SMN1; SMN2HPGDHTTSLC6A5ALDH1A1 | |
| SCHEMBL17168743 | 0.93 | SMN1; SMN2 (0.50) | SMN1; SMN2HPGDHTTALDH1A1HDAC3 | |
| SCHEMBL20999873 | 0.93 | SMN1; SMN2 (0.50) | SMN1; SMN2HPGDHTTALDH1A1HDAC3 | |
| SCHEMBL26382038 | 0.93 | SMN1; SMN2 (0.50) | SMN1; SMN2HPGDHTTALDH1A1HDAC3 | |
| SCHEMBL17767809 | 0.93 | SMN1; SMN2 (0.50) | SMN1; SMN2HPGDHTTALDH1A1HDAC3 | |
| SCHEMBL17767812 | 0.93 | SMN1; SMN2 (0.50) | SMN1; SMN2HPGDHTTALDH1A1HDAC3 | |
| SCHEMBL21117960 | 0.92 | SMN1; SMN2 (0.49) | SMN1; SMN2HPGDHTTALDH1A1HDAC3 | |
| SCHEMBL13405586 | 0.91 | SMN1; SMN2 (0.45) | SMN1; SMN2HPGDHTTSLC6A5ALDH1A1 | |
| SCHEMBL14103627 | 0.88 | SMN1; SMN2 (0.42) | SMN1; SMN2HPGDHTTSLC6A5ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7696185-B2 | N-{[(2S)-2-carboxy-2-({4-[({3-[(2-{[3-carboxy-4-(6-hydroxy-3-oxo-9,9a-dihydro-3H-xanthen-9-yl)phenyl]amino}-2-oxoethyl)thio]-propanoyl}amino)methyl]benzoyl}amino)ethoxy](hydroxy)phosphoryl}-L-glutamic acid; inhibitors of prostate-specific membrane antigen (PMSA); prostate cancer | Cancer Targered Technology LLC (US) | 2010-04-13 | — | — | US | disclosed |
| US-20070219165-A1 | Peptidomimetic Inhibitors Of PSMA, Compounds Comprising Them, And Methods of Use | CANCER TARGETED TECHNOLOGY LLC (US) | 2007-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070219165-A1 | Peptidomimetic Inhibitors Of PSMA, Compounds Comprising Them, And Methods of Use | FOLH1, PSMA1, DNPEP | SMN1; SMN2 4059/4885HPGD 2725/4885HTT 4717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.